See every side of every news story
Published loading...Updated

Promising New Treatment Option for Basal Cell Carcinoma Shows Success

Summary by healtheconomics.com
Researchers from MedUni Vienna and University Hospital Vienna have successfully tested a new treatment for basal cell carcinoma using Talimogene Laherparepvec (TVEC), a genetically modified herpes simplex virus. Previously approved for superficial melanoma metastases, TVEC was administered to 18 patients over 13 weeks, resulting in a significant size reduction of tumors, enabling simpler surgical procedures and, in some cases, complete tumor reg…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

healtheconomics.com broke the news in on Thursday, January 30, 2025.
Sources are mostly out of (0)